Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy (brand-name semaglutide) became a household name after multiple studies demonstrated its ability to help people lose significant amounts of weight. The average participant in the STEP trials lost 15 to 22 percent of their starting body weight within 68 weeks—results that sparked demand across the country. PlexusDx delivers the same FDA-active semaglutide through licensed 503A compounding pharmacies at a fraction of the retail cost.
Average Weight Loss on Semaglutide Injection Therapy
The STEP clinical trials, published between 2021 and 2023, followed over 4,500 adults with overweight or obesity. Participants who received semaglutide 2.4 mg weekly lost an average of 15 percent of their body weight compared to just 2.6 percent in the placebo group. For a 250-pound person, that translates to approximately 37 pounds over the study period. These outcomes remain among the most robust weight loss results in medical literature for a single medication.
Variability in individual results is normal and expected. Some participants lost as much as 22 percent of body weight, while others saw more modest reductions in the 10 to 15 percent range. Factors influencing these differences include baseline metabolic rate, adherence to the injection schedule, dietary habits, physical activity level, and individual genetic responses to the medication. Age, gender, and prior weight loss attempts do not appear to be strong predictors of final outcomes.
How Semaglutide Produces Weight Loss Results
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces to regulate hunger and blood sugar. When you inject semaglutide, it binds to GLP-1 receptors in your brain's appetite center, slowing stomach emptying and creating a sustained sense of fullness. This mechanism reduces calorie intake without requiring willpower-based restriction. Most patients report eating smaller portions and feeling satisfied with less food within the first two weeks of treatment.
The medication also improves how your body handles glucose and may enhance insulin sensitivity over time. This dual action—appetite suppression plus metabolic support—explains why semaglutide delivers results superior to diet and exercise alone for many patients. The effect is dose-dependent, meaning higher doses typically produce greater weight loss, though your dose may need to go up and your price won't at PlexusDx.
Realistic Timeline for Semaglutide Weight Loss
Most patients notice appetite reduction within 3 to 5 days of their first injection. Meaningful weight loss—typically 5 to 10 pounds—becomes visible within 4 to 8 weeks as the cumulative effect of reduced calorie intake compounds. The steepest weight loss curve occurs between weeks 8 and 20, when body composition shifts most rapidly. After 16 weeks, weight loss tends to plateau as your body adapts, though continued gradual loss usually continues through week 68.
Starting at a lower dose and titrating upward (beginning around 0.25 mg and advancing every four weeks) allows your body to adapt while minimizing nausea and gastrointestinal side effects. This gradual approach extends your timeline slightly but improves tolerability and adherence. Patients who maintain consistent weekly injections and combine treatment with modest dietary awareness achieve results closest to the clinical trial averages.
PlexusDx Semaglutide vs. Brand-Name Wegovy Costs
Wegovy retail pricing starts around $900 to $1,350 per month depending on dose strength and pharmacy location. PlexusDx compounded semaglutide injections start at just $149 per month—a reduction of up to 85 percent. Both medications contain the identical active pharmaceutical ingredient (semaglutide); the price difference reflects brand premium, manufacturer rebates, and supply chain markups rather than product quality or efficacy. PlexusDx sources from licensed 503A compounding pharmacies across all 50 states, requiring no insurance and no membership fee.
All PlexusDx semaglutide is HSA and FSA eligible, which further reduces your net cost if you carry either account type. The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes your genetic pathway response to peptide therapy, helping optimize your treatment selection and dosing strategy for maximum results. This personalized approach ensures you're using the medication most likely to work best for your unique biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose with semaglutide in the first month?
Most patients lose 2 to 5 pounds in the first month as appetite suppression kicks in. However, the initial weeks are primarily about dose adjustment and side effect tolerance. Expect more substantial weight loss (7 to 15 pounds) by month three or four once you've reached a therapeutic dose and your body has adapted to the medication.
Do you keep the weight off after stopping semaglutide?
Clinical data shows that weight tends to return if the medication is discontinued without lifestyle changes. However, many patients find that semaglutide resets their relationship with food, making permanent dietary improvements easier to maintain. Some patients use semaglutide as a bridge to establish healthy habits, while others continue long-term therapy to sustain results.
Is PlexusDx semaglutide the same as Wegovy?
Yes, PlexusDx semaglutide contains the identical active ingredient as Wegovy and is produced by licensed 503A compounding pharmacies. The difference is cost: PlexusDx starts at $149/month versus $900+ for brand Wegovy. Your dose may need to go up, but your price won't at PlexusDx.
What side effects occur with semaglutide weight loss treatment?
The most common side effects are nausea, vomiting, and constipation, typically experienced in the first 1 to 4 weeks. These effects usually diminish as your body adjusts. More serious but rare side effects include pancreatitis and gallbladder issues. Slow dose titration minimizes nausea, and staying hydrated plus eating smaller, low-fat meals helps manage gastrointestinal symptoms.
How does the Precision Peptide Genetic Test help with weight loss results?
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways including your GLP-1 receptor sensitivity (GLP1R rs6923761), GIPR response, and FTO appetite-regulation genes. This $99 add-on test reveals your genetic predispositions to semaglutide versus tirzepatide response, optimizing your medication choice and dosing for faster, better results tailored to your unique peptide biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can I Inject Zepbound One Day Early?
Does Everyone Have Side Effects from Wegovy?